Abstract:Background: Hypoxia may play a role in the pathogenesis of infantile hemangioma. Cysteine-rich angiogenic inducer 61 (Cyr61), or CCN1, can be induced under hypoxic conditions in several types of cells. However, whether CCN1 has any impact on infantile hemangioma remains unknown. This study aims to explore the expression of CCN1 in infantile hemangioma and to investigate the effect of hypoxia on CCN1 and vascular endothelial growth factor-A (VEGF-A) production. Methods: Hemangioma-derived endothelial cells and hemangioma-derived stem cells were isolated from surgical specimens of proliferative infantile hemangioma. RNA extracted from infantile hemangioma tissue, hemangioma-derived endothelial cells, and hemangioma-derived stem cells was used to analyze gene expression by real-time polymerase chain reaction. The effects of CCN1 blockade were examined in hemangioma-derived stem cells. Immunostaining, immunoblotting, and enzyme-linked immunosorbent assays were used to assess protein expression. Results: By double-label immunofluorescence staining, the authors first identified that CCN1 was abundant in proliferative infantile hemangioma lesions and colocalized well with immature microvessels. The authors found that the mRNA level of CCN1 in proliferative infantile hemangioma was significantly higher than in healthy controls, as was involuting infantile hemangioma. Treatment with the hypoxia inducer cobalt chloride dramatically increased CCN1 production in hemangioma-derived endothelial cells in a time-dependent manner. Furthermore, blocking or knockdown of CCN1 expression reduced the expression of VEGF-A in hemangioma-derived stem cells. Lastly, the signaling pathway study showed that CCN1 up-regulation of VEGF-A synthesis in hemangioma-derived stem cells depends on nuclear factor-κB and JNK activation. Conclusions: These findings provide new evidence that CCN1 participates in the crosstalk between hemangioma-derived endothelial cells and hemangioma-derived stem cells through promoting VEGF-A expression in the hypoxic environment of infantile hemangioma angiogenesis and vasculogenesis. Targeting of CCN1 might be a novel therapeutic strategy for infantile hemangioma.

Association of ATF4 Expression with Tissue Hypoxia and M2 Macrophage Infiltration in Infantile Hemangioma

Macrophages Contribute to the Progression of Infantile Hemangioma by Regulating the Proliferation and Differentiation of Hemangioma Stem Cells.

Hypoxia-induced Autophagy in Endothelial Cells: a Double-Edged Sword in the Progression of Infantile Haemangioma?

Expression and significance of hypoxia inducible factor-1α in different phases of hemangioma and vascular malformation in infants and children

868 Hypoxia Induced Cyr61 Productions Involved in the Pathogenesis of Infantile Hemangioma

M2-polarised Macrophages in Infantile Haemangiomas: Correlation with Promoted Angiogenesis.

Characterization of epigenetic and transcriptional landscape in infantile hemangiomas with ATAC-seq and RNA-seq

[The Relationship Between the Expression of HIF-1alpha and the Angiogenesis in Infancy Hemangioma].

Targeting ESM1 via SOX4 promotes the progression of infantile hemangioma through the PI3K/AKT signaling pathway

Role Of Endothelial-Mesenchymal Transition In The Tumorigenesis Of Infantile Hemangioma

Hypoxia-Induced Cyr61/CCN1 Production in Infantile Hemangioma

Expression of Hypoxia Inducible Factor-1Α, 3α in Hemangioma

Long Noncoding RNA Expression Profile of Infantile Hemangioma Identified by Microarray Analysis

Insights into the mechanisms of angiogenesis in infantile hemangioma

Signaling pathways in the development of infantile hemangioma

CENPF May Act as a Novel Marker and Highlight the Influence of Pericyte in Infantile Hemangioma

Activating Transcription Factor 4 Promotes Angiogenesis of Breast Cancer Through Enhanced Macrophage Recruitment

ALKBH5 facilitates the progression of infantile hemangioma by increasing FOXF1 expression in a m6A-YTHDF2 dependent manner to activate HK-2 signaling

Biology of Infantile Hemangioma

CD146+ mural cells from infantile hemangioma display proangiogenic ability and adipogenesis potential in vitro and in xenograft models

An Integrated Stress Response Pathway activates Perivascular Cancer-Associated Fibroblasts to Drive Angiogenesis and Tumor Progression